Aeterna Zentaris to Announce Fourth Quarter and Full-Year 2007 Financial and Operating Results on Mar... ( QUEBEC CITY Feb. 28 / Aeterna Zen...)

Aeterna Zentaris to Announce Fourth Quarter and Full-Year 2007 Financial and Operating Results on March 5, 2008

Date:2/28/2008

QUEBEC CITY, Feb. 28 /PRNewswire-FirstCall/ - Aeterna Zentaris Inc. (NASDAQ: AEZS, TSX: AEZ), a global biopharmaceutical company focused on endocrine therapy and oncology, will announce its fourth quarter and full-year 2007 financial and operating results before market open on Wednesday, March 5, 2008. The Company will host a conference call and webcast to discuss these results later that same day at 10:00 a.m., Eastern Time.

Participants may access the live webcast via the Company's website at http://www.aezsinc.com in the "Investors" section, or by telephone using the following numbers: 416-644-3425, 514-807-8791 or 800-595-8550. A replay of the webcast will also be available on the Company's website for a period of 30 days.

About Aeterna Zentaris Inc.

Aeterna Zentaris Inc. is global biopharmaceutical company focused on endocrine therapy and oncology with proven expertise in drug discovery, development and commercialization. News releases and additional information are available at http://www.aezsinc.com.

0

GOOD

Page: 1
Related biology technology :

1. AEterna Zentaris to Present at the Upcoming Roth Capital Partners 20th Annual OC Growth Stock Conference in Dana Point, California
2. AEterna Zentaris Reports First Patients Treated with Anti-Cancer Compound AEZS-108 in Phase 2 Trial in Ovarian and Endometrial Cancers
3. AEterna Zentaris to Further Develop Three Follow-up Multi-targeted Cytotoxic Candidates to AEZS-112 as Potential Novel Cancer Treatment
4. AEterna Zentaris Announces Outcome of Managements Strategic Review
5. AEterna Zentaris to Present at Upcoming UBS Global Life Sciences Conference in New York
6. AEterna Zentaris completes management team with the appointment of Chief Medical Officer
7. Kosan Announces Senior Management Changes and Clinical Portfolio Priorities
8. Kosan Announces Fourth Quarter and Full Year 2007 Financial Results and 2008 Outlook
9. Wyeth Announces Executive Change in Finance Organization
10. BioCryst Pharmaceuticals to Announce Fourth Quarter and Fiscal Year 2007 Financial Results on March 4, 2008
11. Insmed Announces Listing Transfer from Nasdaq Global Market to Nasdaq Capital Market

Post Your Comments:

Aeterna Zentaris to Announce Fourth Quarter and Full-Year 2007 Financial and Operating Results on Mar...( QUEBEC CITY Feb. 28 / Aeterna Zen...)